Cases & Deals

Bpifrance sells interests in HalioDx to Veracyte, Inc.

Client(s) Bpifrance

Jones Day represented Bpifrance in the sale of its interests in HalioDx, a French private biotech company specialized in immune-based diagnostic products and services, as part of the €260 million sale of HalioDx to Veracyte, Inc., a U.S. global genomic diagnostics company listed on the Nasdaq.